BioPharma Credit PLC (BOPCF)

OTCMKTS · Delayed Price · Currency is USD
0.9505
0.00 (0.00%)
At close: Mar 26, 2026
Market Cap1.06B +3.1%
Revenue (ttm)157.75M +5.1%
Net Income129.89M +6.3%
EPS0.11 +14.0%
Shares Outn/a
PE Ratio8.15
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,000,833
Average Volume700,044
Open1.0000
Previous Closen/a
Day's Range0.9505 - 1.0000
52-Week Range0.7820 - 1.0000
Beta0.10
RSI55.04
Earnings DateMar 24, 2026

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. The company debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in Leeds, the United Kingdom. [Read more]

Sector Financials
Founded 2016
Country United Kingdom
Stock Exchange OTCMKTS
Ticker Symbol BOPCF

Financial Performance

In 2025, BioPharma Credit's revenue was $157.75 million, an increase of 5.14% compared to the previous year's $150.03 million. Earnings were $129.89 million, an increase of 6.31%.

Financial Statements